AAAAAA

   
Results: 1-7 |
Results: 7
WORSE SURVIVAL OF PATIENTS WITH ENDOMETRIAL CANCER FOLLOWING TAMOXIFEN TREATMENT FOR BREAST-CANCER - A STUDY WITH 309 2ND TUMORS
Authors: BERGMAN L BEELEN MLR GALLEE MPW BENRAADT J VANLEEUWEN FE
Citation: L. Bergman et al., WORSE SURVIVAL OF PATIENTS WITH ENDOMETRIAL CANCER FOLLOWING TAMOXIFEN TREATMENT FOR BREAST-CANCER - A STUDY WITH 309 2ND TUMORS, European journal of cancer, 34, 1998, pp. 99-99
DOES RISK OF ENDOMETRIAL CANCER INCREASE WITH LONGER DURATION OF TAMOXIFEN USE
Authors: VANLEEUWEN F BERGMAN L BENRAADT J
Citation: F. Vanleeuwen et al., DOES RISK OF ENDOMETRIAL CANCER INCREASE WITH LONGER DURATION OF TAMOXIFEN USE, European journal of cancer, 34, 1998, pp. 44-45
POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
Authors: ABE O ABE R ENOMOTO K KIKUCHI K KOYAMA H NOMURA Y SAKAI K SUGIMACHI K TOMINAGA T UCHINO J YOSHIDA M BENRAADT J VANDEVELDE AO VANDONGEN JA VERMORKEN JB GIOKAS G LISSAIOS B HARVEY VJ HOLDAWAY TM KAY RG MASON BH COATES A FORBES JF FOCAN C LOBELLE JP GATES GD POWELL J DURAND M MAURIAC L BARTHOLOMEUS S PICCART MJ GELMAN RS HENDERSON IC SHAPIRO CL HANCOCK AK MASOOD MB PARKER D PRICE JJ JACKSON S RAGAZ J DELOZIER T MACELESECH J HAYBITTLE JL BERRY D BROADWATER G CIRRINCIONE C MUSS H NORTON L BAUM M HOUGHTON J RILEY D DENT DM GUDGEON CA HACKING A GORDON NH DAVIS HL ROMESTAING P LEHINGUE Y OWEN JR MEIER P HOWELL A RIBEIRO GC SWINDELL R ALBANO J DEOLIVEIRA CF GERVASIO H GORDILHO J CARSTENSEN B PALSHOF T JOHANSEN H KORZENIOWSKI S SKOLYSZEWSKI J PORTNOJ SM ANDERSEN KW AXELSSON CK BLICHERTTOFT M MOURIDSEN HT OVERGAARD M ROSE C CORCORAN N TRAMPISCH HJ COMIS RL DAVIDSON NE GRAY R ROBERT N TORMEY DC WOOD W CHETTY U FORREST P JACK W ROSSBACH J SYLVESTER RJ VANDEVELDE CJH CUNNINGHAM MP BONNETERRE J FUMOLEAU P NAMER M BASTERT G RAUSCHECKER H SAUER R SAUERBREI W SCHAUER A SCHUMACHER M DESCHRYVER A BELFIGLIO M MARI E NICOLUCCI A SCORPIGLIONE N YOSEF HMA MCARDLE CS SMITH DC LARA PC BOCCARDO F RUBAGOTTI A ERAZO A MEDINA JY IZUO M MORISHITA Y BENTLEY A DORAN Z FENTIMAN IS HAYWARD JL RUBENS RD KAUFMANN M JONAT W SCHEURLEN H VONFOURNIER D FOUNTZILAS G KLAFSTROM P BLOMQVIST C CUZICK J MARGREITER R CASTIGLIONE M CAVILLI F COLLINS J FORBES J GELBER RD GOLDHIRSCH A LINDTNER J PRICE KN RUDENSTAM CM SENN HJ BLISS JM CHILVERS CED COOMBES RC MARTY M BOROVIK R BRUFMAN G HAYAT H ROBINSON E WIGLER N PANNUTI F TAKASHIMA S YASUTOMI T SONOO H YAMASHITA J OGAWA M WELVAART K HUPPERETS PSGJ BONTE J TENGRUP I TENNVALLNITTBY L MARTIN P ROMAIN S INGLE JN SUMAN VJ BUZDAR AU SMITH T HAKES T WITTES R DELAHUERTA R SAINZ MG BONADONNA G DELVECCHIO M VALAGUSSA P VERONESI U DUBOIS JB BIANCO AR LIPPMAN ME PIERCE LJ SIMON R STEINBERG SM MYLES JD PATER JL PRITCHARD KI ANDERSON S BROWN A BRYANT J COSTANTINO J DIGNAM J FISHER B REDMOND C WIEAND S WOLMARK N JACKSON IM PALMER MK BENGTSSON NO LARSSON LG LYTHGOE JP KISSIN M HANNISDAL E VARHAUG JE NISSENMEYER R BLAMEY RW MITCHELL AK ROBERTSON JFR UEO H MATHE G MISSET JL ABUZAHRA HT CLARKE EA MCLAUGHLIN JR CLARK RM LEVINE M MORIMOTO K SAWA K TAKATSUKA Y GUNDERSEN S HAUERJENSEN M HOST H CROSSLEY E HARRIS A BEIGHTON A CLARKE M COLLINS R DAVIES C EVANS V GODWIN J GREAVES E HARWOOD C JACKSON D JAMES S LAU E MEAD G NAUGHTEN A PETO R TOOTH A RAMBERT P ASSELAIN B SALMON RJ VILCOQ JR ARRIAGADA R HILL C LAPLANCHE A LE MG SPIELMANN M COCCONI G DIBLASIO B CATALANO R CREECH RH BROCKSCHMIDT J COOPER MR ANDRYSEK O BARKMANOVA J FALKSON CI ABRAHAM M KLIJN JGM TREURNIETDONKER AD VANPUTTEN WLJ EASTON D POWLES TJ GAZET JC SEMIGLAZOV V DESHPANDE N DIMARTINO L DOUGLAS P LINDTNER A NOTTER G BRYANT AJS EWING GH KRUSHENKOSLOSKI JL GEORGE WD GOULD A STEWART HJ STRONER P MOLLER TR RYDEN S CARSTENSEN J HATSCHEK T SODERBERG M CARPENTER JT ALBAIN K CROWLEY J GREEN S MARTINO S OSBORNE CK RAVDIN PM RUTQVIST LE WALLGREN A HOLM LE THURLIMANN B BRENNER H HERCBERGS A YOSHIMOTO M DEBOER G PATERSON AHG MEAKIN JW PANZARELLA T NAJA A BAHI J REID M SPITTLE M SENANAYAKE F BERGH J HOLMBERG L SEVELDA P ZIELINSKY CC GNANT M JAKESZ R BUCHANAN RB CROSS M DUNN JA GILLESPIE WM KELLY K MORRISON JM LITTON A CHLEBOWSKI RT BEZWODA WR CAFFIER H
Citation: O. Abe et al., POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS, Lancet, 352(9132), 1998, pp. 930-942
THE EFFECT OF TAMOXIFEN ON THE RISK AND PROGNOSIS OF ENDOMETRIAL CANCER FOLLOWING BREAST-CANCER
Authors: VANLEEUWEN FE BERGMAN L BEELEN MLR GALLEE MPW BENRAADT J
Citation: Fe. Vanleeuwen et al., THE EFFECT OF TAMOXIFEN ON THE RISK AND PROGNOSIS OF ENDOMETRIAL CANCER FOLLOWING BREAST-CANCER, American journal of epidemiology, 147(11), 1998, pp. 256-256
FEASIBILITY OF ESCALATING DAILY DOSES OF CISPLATIN IN COMBINATION WITH ACCELERATED RADIOTHERAPY IN NONSMALL CELL LUNG-CANCER
Authors: SCHUSTERUITTERHOEVE ALJ VANDEVAART PJM SCHAAKEKONING CCE BENRAADT J KOOLEN MGJ GONZALEZ DG BARTELINK H
Citation: Alj. Schusteruitterhoeve et al., FEASIBILITY OF ESCALATING DAILY DOSES OF CISPLATIN IN COMBINATION WITH ACCELERATED RADIOTHERAPY IN NONSMALL CELL LUNG-CANCER, European journal of cancer, 32A(8), 1996, pp. 1314-1319
TAMOXIFEN, BALANCING RISKS AND BENEFITS
Authors: BERGMAN L BENRAADT J VANLEEUWEN FE
Citation: L. Bergman et al., TAMOXIFEN, BALANCING RISKS AND BENEFITS, Netherlands journal of medicine, 49(6), 1996, pp. 228-234
RISK OF ENDOMETRIAL CANCER AFTER TAMOXIFEN TREATMENT OF BREAST-CANCER
Authors: VANLEEUWEN FE BENRAADT J COEBERGH JWW KIEMENEY LALM GIMBRERE CHF OTTER R SCHOUTEN LJ DAMHUIS RAM BONTENBAL M DIEPENHORST FW VANDENBELTDUSEBOUT AW VANTINTEREN H
Citation: Fe. Vanleeuwen et al., RISK OF ENDOMETRIAL CANCER AFTER TAMOXIFEN TREATMENT OF BREAST-CANCER, Lancet, 343(8895), 1994, pp. 448-452
Risultati: 1-7 |